secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2026-08-10T20:04:20+00:00
Accession:  0001104659-26-093346
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q2 revenue up 9% to $85.7M, EPS $0.34, FY26 guidance narrowed
-----------------------------------------------------------------------------

- Q2 2026 revenue $85.7M, +9% YoY; net income $7.8M vs $3.2M; diluted EPS $0.34 vs $0.14
- Adjusted EBITDA $11.4M vs $7.7M; gross margin 76% vs 75%; lymphedema +12%, airway clearance -7%
- Six-month revenue $161.0M +15% YoY; net income $6.0M vs $0.2M; adjusted EBITDA $15.1M vs $7.4M
- FY2026 revenue guidance narrowed to $360-366M (from $360-368M); adjusted EBITDA maintained at $49-51M
- Exclusive U.S. VA/DoD distribution deal for ElastiMed's MyoSleeve; launched next-gen AffloVest; $5.3M share repurchase

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000110465926093346/0001104659-26-093346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000110465926093346/tcmd-20260810x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-093346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer